Skip to content

Effect of powdered Berberis vulgaris on vascular function

Comparison of the effect of powdered Berberis vulgaris and placebo consumption on flow mediated dilation and vascular inflammatory biomarkers in hypertensive subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20160702028742N8
Enrollment
76
Registered
2020-03-20
Start date
2020-01-21
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group: Daily consumption of 10 gram of barberry powder for 8 weeks. Barberry is purchased from the local market at one time. Intervention 2: Control group: Daily consumpti

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: Willingness to participate in the study Age between 20-65 years Having elevated blood pressure (129/ < 85) or known hypertensive patients on medical treatment At least one other classical cardiovascular disease risk factors, including hyperlipidemia or diabetes mellitus

Exclusion criteria

Exclusion criteria: BMI> 30 Patients on nitrate drugs High doses of statins consumption (Atorvastatin>40 mg/day or Rosuvastatin>20 mg/day) Regular consumption (more than once in a week) of vitamins or minerals supplements during past month Chronic kidney disease stage 4 or 5

Design outcomes

Primary

MeasureTime frame
Flow mediated dilation (FMD). Timepoint: Baseline and the end of the study. Method of measurement: sonography.

Secondary

MeasureTime frame
Plasma ICAM-1. Timepoint: Baseline and the end of the study. Method of measurement: ELISA.;Plasma VCAM-1. Timepoint: Baseline and the end of the study. Method of measurement: ELISA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHadi Emamat

Shahid Beheshti University of Medical Sciences

hadiemamat@yahoo.com+98 31 5545 0314

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 16, 2026